Impact of sex on cardiac troponin concentrations-A critical appraisal

Clinical Chemistry

Volumn 63, Issue 9, 2017, Pages 1457-1464

  Eggers, Kai M ^a   Lindahl, Bertil ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN; TROPONIN T;

ACUTE CORONARY SYNDROME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HUMAN; MALE; PROTEIN BLOOD LEVEL; REVIEW; SEX DIFFERENCE; THORAX PAIN; BIOASSAY; BLOOD; DEVICES; RISK FACTOR; SEX FACTOR; STANDARDS;

BIOLOGICAL ASSAY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; RISK FACTORS; SEX FACTORS; TROPONIN T;

EID: 85028499139     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2017.271684     Document Type: Review

References (54)

1. White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol 2011;57:2406-8. Erratum in: J Am Coll Cardiol 2011;58:2356.
2. Alpert JS, Thygesen A, Antman EM, Bassand JP. Myocardial infarction redefined-a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000;36:959-69.
3. Sandoval Y, Apple FS. The global need to define normality: the 99th percentile value of cardiac troponin. Clin Chem 2014;60:455-62.
4. Apple FS, Sandoval Y, Jaffe AS, Ordonez-Llanos J; IFCC Task Force on Clinical Applications of Cardiac Bio-Markers. Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clin Chem 2017;63:73-81.
5. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Circulation 2012;126:2020-35.
6. Apple FS, Jaffe AS. Men are different than women: it's true for cardiac troponin too. Clin Biochem 2014;47: 867-8.
7. Cullen LA, Mills NL. Point: the use of sex-specific cutpoints for high-sensitivity cardiac troponin assays. Clin Chem 2017;63:261-3.
8. Giannitsis E. Counterpoint: potential concerns regarding the use of sex-specific cutpoints for high-sensitivity troponin assays. Clin Chem 2017;63:264-6.
9. Gore MO, Seliger SL, Defilippi CR, Nambi V, Christenson RH, Hashim IA, et al. Age-and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol 2014;63:1441-8.
10. Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta 2011; 412:748-54.
11. U.S. Food & Drug Administration. http://www.access data.fda.gov/cdrh-docs/reviews/K162895.pdf (Accessed February 2017).
12. Kimenai DM, Henry RM, van der Kallen CJ, Dagnelie PC, Schram MT, Stehouwer CD, et al. Direct comparison of clinical decision limits for cardiac troponin T and I. Heart 2016;102:610-6.
13. Salton CJ, Chuang ML, O'Donnell CJ, Kupka MJ, Larson MG, Kissinger KV, et al. Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort. J Am Coll Cardiol 2002;39:1055-60.
14. Laufer EM, Mingels AM, Winkens MH, Joosen IA, Schellings MW, Leiner T, et al. The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T. Arterioscler Thromb Vasc Biol 2010;30:1269-75.
15. Piro M, Della Bona R, Abbate A, Biasucci LM, Crea F. Sex-related differences in myocardial remodeling. J Am Coll Cardiol 2010;55:1057-65.
16. Westerman S, Wenger NK. Women and heart disease, the underrecognized burden: sex differences, biases, and unmet clinical and research challenges. Clin Sci (Lond) 2016;130:551-63.
17. Eggers KM, Johnston N, Lind L, Venge P, Lindahl B. Cardiac troponin I levels in an elderly population from the community-The implications of sex. Clin Biochem 2015;48:751-6.
18. Sinning C, Keller T, Zeller T, Ojeda F, Schlü ter M, Schnabel R, et al. Association of high-sensitivity assayed troponin I with cardiovascular phenotypes in the general population: the population-based Gutenberg health study. Clin Res Cardiol 2014;103:211-22.
19. Masson S, Latini R, Mureddu GF, Agabiti N, Miceli M, Cesaroni G, et al. High-sensitivity cardiac troponin T for detection of subtle abnormalities of cardiac phenotype in a general population of elderly individuals. J Intern Med 2013;273:306-17.
20. Zeller T, Tunstall-Pedoe H, Saarela O, Ojeda F, Schnabel RB, Tuovinen T, et al. High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort. Eur Heart J 2014;35: 271-81.
21. Omland T, de Lemos JA, Holmen OL, Dalen H, Benth JS? , Nygård S, et al. Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: the HUNT Study. Clin Chem 2015;61: 646-56.
22. Dallmeier D, Denkinger M, Peter R, Rapp K, Jaffe AS, Koenig W, et al. Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study. Clin Chem 2015; 61:389-99.
23. Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011; 123:1367-76.
24. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;304: 2503-12. Erratum in: JAMA 2011;305:1200.
25. McQueen MJ, Kavsak PA, Xu L, Shestakovska O, Yusuf S. Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a high-risk stable population. Clin Biochem 2013;46:5-9.
26. Harada Y, Michel J, Koenig W, Rheude T, Colleran R, Giacoppo D, et al. Prognostic value of cardiac troponin T and sex in patients undergoing elective percutaneous coronary intervention. J Am Heart Assoc 2016;5: e004464.
27. Everett BM, Brooks MM, Vlachos HE, Chaitman BR, Frye RL, Bhatt DL, et al. Sex differences in cardiac troponin and the risk of death or major cardiovascular events. J Am Coll Cardiol 2016;68:978-80.
28. Beatty AL, Ku IA, Christenson RH, DeFilippi CR, Schiller NB, Whooley MA. High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study. JAMA Intern Med 2013;173:763-9.
29. Eisen A, Bonaca MP, Jarolim P, Scirica BM, White HD, Tendera M, et al. High-sensitivity troponin I in stable patients with atherosclerotic disease in the TRA 2P-TIMI 50 trial. Clin Chem 2017;63:307-15.
30. Eggers KM, Lindahl B. Application of cardiac troponin in cardiovascular diseases other than acute coronary syndrome. Clin Chem 2017;63:223-35.
31. Gravning J, Askevold ET,NymoSH, Ueland T, Wikstrand J, McMurray JJ, et al. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial. Circ Heart Fail 2014;7:96-103.
32. Grodin JL, Neale S,WuY, Hazen SL, Tang WH. Prognostic comparison of different sensitivity cardiac troponin assays in stable heart failure. Am J Med 2015;128: 276-82.
33. Eggers KM, Nygren M, Venge P, Jernberg T, Wikström BG. High-sensitive troponin T and I are markers of disease severity and mortality in patients with leftventricular dysfunction and precapillary pulmonary hypertension-high-sensitive troponins in relation to invasive hemodynamic data and outcome. Clin Chim Acta 2011;412:1582-8.
34. Egstrup M, Schou M, Tuxen CD, Kistorp CN, Hildebrandt PR, Gustafsson F, et al
35. Shah AS, Griffiths M, Lee KK, McAllister DA, Hunter AL, Ferry AV, et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ 2015;350:g7873. Erratum in: BMJ 2015;350:h626.
36. Rubini Giménez M, Twerenbold R, Boeddinghaus J, Nestelberger T, Puelacher C, Hillinger P, et al. Clinical effect of sex-specific cutoff values of high-sensitivity cardiac troponin T in suspected myocardial infarction. JAMA Cardiol 2016;1:912-20.
37. Cullen L, Greenslade JH, Carlton EW, Than M, Pickering JW, Ho A, et al. Sex-specific versus overall cut points for a high sensitivity troponin I assay in predicting 1-year outcomes in emergency patients presenting with chest pain. Heart 2016;102:120-6.
38. Mueller-Hennessen M, Lindahl B, Giannitsis E, Biener M, Vafaie M, deFilippi CR, et al. Diagnostic and prognostic implications using age-and gender-specific cutoffs for high-sensitivity cardiac troponin T-sub-analysis from the TRAPID-AMI study. Int J Cardiol 2016;209: 26-33.
39. Reichlin T, Irfan A, Twerenbold R, Reiter M, Hochholzer W, Burkhalter H, et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011;124:136-45.
40. Rubini Gimenez M, Twerenbold R, Wildi K, Reichlin T, Mueller C. Safety and efficacy of the novel ESC 0h/1hprotocol for rapid rule-out of myocardial infarction among men and women. Eur Heart J 2016;37 Abstract Suppl:980.
41. Eggers KM, Jernberg T, Lindahl B. Prognostic importance of sex-specific cardiac troponin T 99(th) percentiles in suspected acute coronary syndrome. Am J Med 2016;129:880.e1-880.e12.
42. Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L; FRISC II (Fast Revascularization during InStability in CAD) Investigators. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 2001; 38:979-86.
43. Hallén J. Troponin for the estimation of infarct size: what have we learned? Cardiology 2012;121:204-12.
44. Bohula May EA, Bonaca MP, Jarolim P, Antman EM, Braunwald E, Giugliano RP, et al. Prognostic performance of a high-sensitivity cardiac troponin assay in patients with non-ST-elevation acute coronary syndrome. Clin Chem 2014;60:158-64.
45. Eggers KM, Johnston N, James S, Lindahl B, Venge P. Cardiac troponin I levels in patients with non-STelevation acute coronary syndrome-the importance of gender. Am Heart J 2014;168:317-324.e1.
46. Lansky AJ, Ng VG, Maehara A, Weisz G, Lerman A, Mintz GS, et al. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. JACC Cardiovasc Imaging 2012;5 Suppl:S62-72.
47. Wildi K, Gimenez MR, Twerenbold R, Reichlin T, Jaeger C, Heinzelmann A, et al. Misdiagnosis of myocardial infarction related to limitations of the current regulatory approach to define clinical decision values for cardiac troponin. Circulation 2015;131:2032-40.
48. Wildi K, Twerenbold R, Jaeger C, Rubini Giménez M, Reichlin T, Stoll M, et al. Clinical impact of the 2010-2012 low-end shift of high-sensitivity cardiac troponin T. Eur Heart J Acute Cardiovasc Care 2016;5:399-408.
49. Bandstein N, Ljung R, Johansson M, Holzmann MJ. Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol 2014;63:2569-78.
50. Rubini Giménez M, Hoeller R, Reichlin T, Zellweger C, Twerenbold R, Reiter M, et al. Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int J Cardiol 2013; 168:3896-901.
51. Jaeger C, Wildi K, Twerenbold R, Reichlin T, Rubini Gimenez M, Neuhaus JD, et al. One-hour rule-in and rule-out of acute myocardial infarction using highsensitivity cardiac troponin I.AmHeart J 2016;171:92-102.e1-5.
52. Body R, Reynard C. One shot to rule out: does the limit of detection of a high-sensitivity troponin assay hit the mark? Clin Chem 2017;63:21-3.
53. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent STSegment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267-315.
54. Eggers KM, Aldous S, Greenslade JH, Johnston N, Lindahl B, Parsonage WA, et al. Two-hour diagnostic algorithms for early assessment of patients with acute chest pain-Implications of lowering the cardiac troponin I cut-off to the 97.5th percentile. Clin Chim Acta 2015; 445:19-24.